Epithelial Ovarian Cancer Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: EB71A7D39F7EEN
Market Monitor Global

Abstracts

Epithelial ovarian cancer is a disease in which malignant cells develop in the tissue that covers the ovary. Epithelial ovarian cancer is common in women who have a close relation such as mother, daughter, or sister diagnosed with the disease.

This report contains market size and forecasts of Epithelial Ovarian Cancer Treatment in Global, including the following market information:

Global Epithelial Ovarian Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Epithelial Ovarian Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Epithelial Ovarian Cancer Treatment include C. H. Boehringer Sohn, Takeda, Amgen, ImmunoGen, AbbVie, Bayer, Synta Pharmaceuticals, Prima BioMed and Oasmia Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epithelial Ovarian Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epithelial Ovarian Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Epithelial Ovarian Cancer Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Chemotherapy
• Radiation Therapy

Global Epithelial Ovarian Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Epithelial Ovarian Cancer Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Center
• Others

Global Epithelial Ovarian Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Epithelial Ovarian Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Epithelial Ovarian Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Epithelial Ovarian Cancer Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• C. H. Boehringer Sohn
• Takeda
• Amgen
• ImmunoGen
• AbbVie
• Bayer
• Synta Pharmaceuticals
• Prima BioMed
• Oasmia Pharmaceutical
• Glycotope

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epithelial Ovarian Cancer Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epithelial Ovarian Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPITHELIAL OVARIAN CANCER TREATMENT OVERALL MARKET SIZE

2.1 Global Epithelial Ovarian Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Epithelial Ovarian Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epithelial Ovarian Cancer Treatment Players in Global Market
3.2 Top Global Epithelial Ovarian Cancer Treatment Companies Ranked by Revenue
3.3 Global Epithelial Ovarian Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Epithelial Ovarian Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epithelial Ovarian Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epithelial Ovarian Cancer Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Epithelial Ovarian Cancer Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epithelial Ovarian Cancer Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Epithelial Ovarian Cancer Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgery
  4.1.3 Chemotherapy
  4.1.4 Radiation Therapy
4.2 By Type - Global Epithelial Ovarian Cancer Treatment Revenue & Forecasts
  4.2.1 By Type - Global Epithelial Ovarian Cancer Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Epithelial Ovarian Cancer Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epithelial Ovarian Cancer Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Center
  5.1.4 Others
5.2 By Application - Global Epithelial Ovarian Cancer Treatment Revenue & Forecasts
  5.2.1 By Application - Global Epithelial Ovarian Cancer Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Epithelial Ovarian Cancer Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Epithelial Ovarian Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Epithelial Ovarian Cancer Treatment Revenue & Forecasts
  6.2.1 By Region - Global Epithelial Ovarian Cancer Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Epithelial Ovarian Cancer Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Epithelial Ovarian Cancer Treatment Revenue, 2017-2028
  6.3.2 US Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.3.3 Canada Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.3.4 Mexico Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Epithelial Ovarian Cancer Treatment Revenue, 2017-2028
  6.4.2 Germany Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.3 France Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.4 U.K. Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.5 Italy Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.6 Russia Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.4.8 Benelux Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Epithelial Ovarian Cancer Treatment Revenue, 2017-2028
  6.5.2 China Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.5.3 Japan Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.5.4 South Korea Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.5.6 India Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Epithelial Ovarian Cancer Treatment Revenue, 2017-2028
  6.6.2 Brazil Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.6.3 Argentina Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epithelial Ovarian Cancer Treatment Revenue, 2017-2028
  6.7.2 Turkey Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.7.3 Israel Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Epithelial Ovarian Cancer Treatment Market Size, 2017-2028
  6.7.5 UAE Epithelial Ovarian Cancer Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 C. H. Boehringer Sohn
  7.1.1 C. H. Boehringer Sohn Corporate Summary
  7.1.2 C. H. Boehringer Sohn Business Overview
  7.1.3 C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.1.4 C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.1.5 C. H. Boehringer Sohn Key News
7.2 Takeda
  7.2.1 Takeda Corporate Summary
  7.2.2 Takeda Business Overview
  7.2.3 Takeda Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.2.4 Takeda Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.2.5 Takeda Key News
7.3 Amgen
  7.3.1 Amgen Corporate Summary
  7.3.2 Amgen Business Overview
  7.3.3 Amgen Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.3.4 Amgen Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.3.5 Amgen Key News
7.4 ImmunoGen
  7.4.1 ImmunoGen Corporate Summary
  7.4.2 ImmunoGen Business Overview
  7.4.3 ImmunoGen Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.4.4 ImmunoGen Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.4.5 ImmunoGen Key News
7.5 AbbVie
  7.5.1 AbbVie Corporate Summary
  7.5.2 AbbVie Business Overview
  7.5.3 AbbVie Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.5.4 AbbVie Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.5.5 AbbVie Key News
7.6 Bayer
  7.6.1 Bayer Corporate Summary
  7.6.2 Bayer Business Overview
  7.6.3 Bayer Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.6.4 Bayer Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bayer Key News
7.7 Synta Pharmaceuticals
  7.7.1 Synta Pharmaceuticals Corporate Summary
  7.7.2 Synta Pharmaceuticals Business Overview
  7.7.3 Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.7.4 Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.7.5 Synta Pharmaceuticals Key News
7.8 Prima BioMed
  7.8.1 Prima BioMed Corporate Summary
  7.8.2 Prima BioMed Business Overview
  7.8.3 Prima BioMed Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.8.4 Prima BioMed Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.8.5 Prima BioMed Key News
7.9 Oasmia Pharmaceutical
  7.9.1 Oasmia Pharmaceutical Corporate Summary
  7.9.2 Oasmia Pharmaceutical Business Overview
  7.9.3 Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.9.4 Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.9.5 Oasmia Pharmaceutical Key News
7.10 Glycotope
  7.10.1 Glycotope Corporate Summary
  7.10.2 Glycotope Business Overview
  7.10.3 Glycotope Epithelial Ovarian Cancer Treatment Major Product Offerings
  7.10.4 Glycotope Epithelial Ovarian Cancer Treatment Revenue in Global Market (2017-2022)
  7.10.5 Glycotope Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Epithelial Ovarian Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Epithelial Ovarian Cancer Treatment Market Drivers in Global Market
Table 3. Epithelial Ovarian Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Epithelial Ovarian Cancer Treatment in Global Market
Table 5. Top Epithelial Ovarian Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epithelial Ovarian Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epithelial Ovarian Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epithelial Ovarian Cancer Treatment Product Type
Table 9. List of Global Tier 1 Epithelial Ovarian Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epithelial Ovarian Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epithelial Ovarian Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epithelial Ovarian Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epithelial Ovarian Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epithelial Ovarian Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. C. H. Boehringer Sohn Corporate Summary
Table 31. C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Product Offerings
Table 32. C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Takeda Corporate Summary
Table 34. Takeda Epithelial Ovarian Cancer Treatment Product Offerings
Table 35. Takeda Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Epithelial Ovarian Cancer Treatment Product Offerings
Table 38. Amgen Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ImmunoGen Corporate Summary
Table 40. ImmunoGen Epithelial Ovarian Cancer Treatment Product Offerings
Table 41. ImmunoGen Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AbbVie Corporate Summary
Table 43. AbbVie Epithelial Ovarian Cancer Treatment Product Offerings
Table 44. AbbVie Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bayer Corporate Summary
Table 46. Bayer Epithelial Ovarian Cancer Treatment Product Offerings
Table 47. Bayer Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Synta Pharmaceuticals Corporate Summary
Table 49. Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Product Offerings
Table 50. Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Prima BioMed Corporate Summary
Table 52. Prima BioMed Epithelial Ovarian Cancer Treatment Product Offerings
Table 53. Prima BioMed Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Oasmia Pharmaceutical Corporate Summary
Table 55. Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Product Offerings
Table 56. Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Glycotope Corporate Summary
Table 58. Glycotope Epithelial Ovarian Cancer Treatment Product Offerings
Table 59. Glycotope Epithelial Ovarian Cancer Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Epithelial Ovarian Cancer Treatment Segment by Type in 2021
Figure 2. Epithelial Ovarian Cancer Treatment Segment by Application in 2021
Figure 3. Global Epithelial Ovarian Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epithelial Ovarian Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epithelial Ovarian Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epithelial Ovarian Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epithelial Ovarian Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epithelial Ovarian Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takeda Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ImmunoGen Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AbbVie Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Prima BioMed Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Glycotope Epithelial Ovarian Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)